Director, Regulatory Affairs
EligibilityRemote, United Kingdom only
Languages
£111.1k–£141.8k/yr
Company profile
Observed names Recursion Pharmaceuticals
Recursion (NASDAQ: RXRX) is a clinical-stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need.
12 observationsLast observed
2 open roles